AirSculpt Technologies (NASDAQ:AIRS) Stock Rating Upgraded by Wall Street Zen

AirSculpt Technologies (NASDAQ:AIRS) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

Several other equities analysts have also recently issued reports on the company. Leerink Partners set a $4.50 price objective on AirSculpt Technologies in a report on Thursday, May 14th. Weiss Ratings reissued a “sell (e+)” rating on shares of AirSculpt Technologies in a report on Tuesday, June 9th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $4.50.

AirSculpt Technologies Trading Up 3.4%

Shares of AirSculpt Technologies stock opened at $4.57 on Friday. The company has a 50-day moving average of $4.35 and a two-hundred day moving average of $3.08. AirSculpt Technologies has a 12-month low of $1.51 and a 12-month high of $12.00. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.39. The stock has a market cap of $322.41 million, a PE ratio of -26.88 and a beta of 2.31.

AirSculpt Technologies (NASDAQ:AIRS) last announced its quarterly earnings results on Tuesday, March 31st. The company reported ($0.02) EPS for the quarter, hitting the consensus estimate of ($0.02). The business had revenue of $33.44 million for the quarter. AirSculpt Technologies had a negative return on equity of 4.98% and a negative net margin of 7.39%.AirSculpt Technologies’s revenue for the quarter was down 14.8% on a year-over-year basis.

Insider Transactions at AirSculpt Technologies

In other AirSculpt Technologies news, major shareholder Jorey Chernett purchased 90,000 shares of AirSculpt Technologies stock in a transaction on Friday, April 3rd. The shares were bought at an average price of $2.82 per share, with a total value of $253,800.00. Following the completion of the acquisition, the insider directly owned 6,933,761 shares of the company’s stock, valued at approximately $19,553,206.02. This trade represents a 1.32% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have bought a total of 210,000 shares of company stock worth $583,200 in the last ninety days. Insiders own 44.60% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of AIRS. Invesco Ltd. purchased a new stake in AirSculpt Technologies in the 1st quarter valued at approximately $56,000. Creative Planning grew its holdings in AirSculpt Technologies by 32.2% during the 2nd quarter. Creative Planning now owns 13,225 shares of the company’s stock valued at $64,000 after buying an additional 3,224 shares during the last quarter. WINTON GROUP Ltd purchased a new position in AirSculpt Technologies during the second quarter worth $106,000. Jane Street Group LLC purchased a new position in AirSculpt Technologies during the second quarter worth $60,000. Finally, Balyasny Asset Management L.P. raised its holdings in shares of AirSculpt Technologies by 128.5% in the second quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock worth $5,380,000 after acquiring an additional 626,309 shares during the last quarter. 91.54% of the stock is owned by hedge funds and other institutional investors.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.